Santyl Applications to Diabetic Foot Ulcers
Public ClinicalTrials.gov record NCT02111291. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The current trial examines the potential benefits of continuous 12 week treatment with Santyl, measured in terms of wound bed appearance. The visual appearance of granulation tissue will be recorded at each visit for the purpose of examining the relationship between wound bed appearance and progress towards healing. In support of this longer treatment regimen with Santyl, a recent animal study found that application of Santyl for 12 weeks was safe and well tolerated. Therefore, the present study is designed to test the hypothesis that daily treatment of diabetic foot ulcers (DFU) with Santyl for up to 12 weeks will result in more rapid development of granulation tissue than DFU treated with supportive care.
Study identification
- NCT ID
- NCT02111291
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 215 participants
Conditions and interventions
Conditions
Interventions
- Collagenase SANTYL® Ointment Biological
- Hydrogel (if needed) and foam dressing Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2014
- Primary completion
- Nov 30, 2015
- Completion
- Nov 30, 2015
- Last update posted
- Feb 16, 2016
2014 – 2015
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mesa | Arizona | 85206 | — |
| Not listed | Carlsbad | California | 92009 | — |
| Not listed | Castro Valley | California | 94546 | — |
| Not listed | Fair Oaks | California | 95628 | — |
| Not listed | Fresno | California | 93720 | — |
| Not listed | Sylmar | California | 91342 | — |
| Not listed | Doral | Florida | 33178 | — |
| Not listed | Warner Robins | Georgia | 31093 | — |
| Not listed | Shreveport | Louisiana | 71101 | — |
| Not listed | Baltimore | Maryland | 21215 | — |
| Not listed | Kansas City | Missouri | 64114 | — |
| Not listed | Las Vegas | Nevada | 89119 | — |
| Not listed | New York | New York | 10025 | — |
| Not listed | Greenville | North Carolina | 27834 | — |
| Not listed | Reading | Pennsylvania | 19610 | — |
| Not listed | York | Pennsylvania | 17402 | — |
| Not listed | Fort Worth | Texas | 76104 | — |
| Not listed | McAllen | Texas | 78501 | — |
| Not listed | Temple | Texas | 76504 | — |
| Not listed | St. George | Utah | 84770 | — |
| Not listed | Roanoke | Virginia | 24013 | — |
| Not listed | Virginia Beach | Virginia | 23464 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02111291, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2016 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02111291 live on ClinicalTrials.gov.